查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1556565

祛痰药市场报告：2030 年趋势、预测与竞争分析

Expectorant Drug Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

祛痰趋势与预测

预计到 2030 年，全球祛痰药市场预计将达到 211 亿美元，2024 年至 2030 年的复合年增长率为 4.2%。这个市场的主要驱动力是导致喉咙干燥的干咳发病率上升、气喘和慢性阻塞性肺病（COPD）等呼吸系统疾病发病率上升，以及药物配方和给药方式的变化。 。全球祛痰药市场前景广阔，医院药局、零售、药局和网路药局市场充满机会。

按部位分類的祛痰药

本研究按药物类型、剂型、产品类型、分销管道和地区对全球祛痰药市场进行了预测。

祛痰药市场洞察

Lucintel 预测，在预测期内，促分泌剂仍将占据较大份额，因为它们有益于治疗多种呼吸系统疾病。

零售店将继续成为该市场最大的部分。

由于研发活动的增加以及政府政策和核准的不断变化，北美在预测期内将继续成为最大的地区。

常问问题

Q1.市场规模为：

A1. 到 2030 年，全球祛痰药市场预计将达到 211 亿美元。

Q2.市场成长预测是多少：

A2. 2024年至2030年，全球祛痰药市场预计复合年增长率为4.2%。

Q3.影响市场成长的主要驱动因素是：

A3.该市场的主要驱动力是导致喉咙干燥的干咳发病率增加、气喘和慢性阻塞性肺病（COPD）等呼吸系统疾病的发病率增加，以及通过改善祛痰剂的性能。 。

Q4.市场的主要细分市场是：

A4. 全球祛痰药市场前景广阔，医院药局、零售、药局和网路药局市场充满机会。

Q5.市场的主要企业是：

A5. 主要祛痰药公司如下：

  • Abbott Laboratories
  • Acella Pharmaceuticals
  • AstraZeneca
  • Cipla Limited
  • Dabur
  • Glenmark Pharmaceuticals
  • Johnson and Johnson
  • Merck
  • Novartis International
  • Pfizer

Q6.未来最大的细分市场是什么？

A6.Lucintel 预计促泌剂在预测期内仍将占据更大的市场份额，因为它们有益于治疗多种呼吸系统疾病。

Q7. 未来五年预计哪些地区的市场成长最大？

A7. 由于研发活动的增加以及政府政策和核准的进展，预计北美在预测期内仍将是最大的地区。

Q8. 可以客製化报告吗？

A8. 是的，Lucintel 提供 10% 的客製化服务，无需额外付费。

目录

第一章执行摘要

第二章全球祛痰药市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球祛痰药市场趋势（2018-2023）与预测（2024-2030）
  • 按药物类型分類的全球祛痰药市场
    • 分泌刺激剂
    • 黏液溶解药物
  • 按剂型分類的全球祛痰药市场
    • 口服固态剂型
    • 口服液
    • 吸入剂
  • 按产品类型分類的全球祛痰药市场
    • 商店药 (OTC)
    • 处方药
  • 按分销管道分類的全球祛痰药市场
    • 医院药房
    • 零售店
    • 药局
    • 网路药房
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 全球祛痰药市场（按地区）
  • 北美祛痰药市场
  • 欧洲祛痰药市场
  • 亚太祛痰药市场
  • 其他地区祛痰药市场

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 按药物类型分類的全球祛痰药市场成长机会
    • 按剂型分類的全球祛痰药市场成长机会
    • 按产品类型分類的全球祛痰剂市场成长机会
    • 按分销管道分類的全球祛痰药市场成长机会
    • 按地区分類的全球祛痰药市场成长机会
  • 全球祛痰药市场的新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球祛痰药市场产能
    • 全球祛痰药市场的合併、收购与合资
    • 认证和许可

第七章主要企业概况

  • Abbott Laboratories
  • Acella Pharmaceuticals
  • AstraZeneca
  • Cipla Limited
  • Dabur
  • Glenmark Pharmaceuticals
  • Johnson and Johnson
  • Merck
  • Novartis International
  • Pfizer
简介目录

Expectorant Drug Trends and Forecast

The future of the global expectorant drug market looks promising with opportunities in the hospital pharmacy, retail store, drug store, and online pharmacy markets. The global expectorant drug market is expected to reach an estimated $21.1 billion by 2030 with a CAGR of 4.2% from 2024 to 2030. The major drivers for this market are growing number of incidences of dry cough that lead to dry throats, rising rates of respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), as well as, improvements in the performance of expectorant drugs owing to developments and advances in drug formulation and delivery methods.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Expectorant Drug by Segment

The study includes a forecast for the global expectorant drug by drug type, dosage form, product type, distribution channel, and region.

Expectorant Drug Market by Drug Type [Shipment Analysis by Value from 2018 to 2030]:

  • Secretion Enhancer
  • Mucolytics

Expectorant Drug Market by Dosage Form [Shipment Analysis by Value from 2018 to 2030]:

  • Oral Solid
  • Oral Liquid
  • Inhalant

Expectorant Drug Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Over-The-Counter
  • Prescription Drug

Expectorant Drug Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Hospital Pharmacies
  • Retail Store
  • Drug Store
  • Online Pharmacies
  • Others

Expectorant Drug Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Expectorant Drug Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies expectorant drug companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the expectorant drug companies profiled in this report include-

  • Abbott Laboratories
  • Acella Pharmaceuticals
  • AstraZeneca
  • Cipla Limited
  • Dabur
  • Glenmark Pharmaceuticals
  • Johnson and Johnson
  • Merck
  • Novartis International
  • Pfizer

Expectorant Drug Market Insights

Lucintel forecasts that secretion enhancer will remain larger segment over the forecast period due to they are beneficial in the management of several respiratory conditions.

Within this market, retail store will remain the largest segment.

North America will remain the largest region over the forecast period due to growing number of research and development activities, along with government policies and approvals in the region.

Features of the Global Expectorant Drug Market

Market Size Estimates: Expectorant drug market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Expectorant drug market size by drug type, dosage form, product type, distribution channel, and region in terms of value ($B).

Regional Analysis: Expectorant drug market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different drug type, dosage form, product type, distribution channel, and regions for the expectorant drug market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the expectorant drug market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the expectorant drug market size?

Answer: The global expectorant drug market is expected to reach an estimated $21.1 billion by 2030.

Q2. What is the growth forecast for expectorant drug market?

Answer: The global expectorant drug market is expected to grow with a CAGR of 4.2% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the expectorant drug market?

Answer: The major drivers for this market are growing number of incidences of dry cough that lead to dry throats, rising rates of respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), as well as, improvements in the performance of expectorant drugs owing to developments and advances in drug formulation and delivery methods.

Q4. What are the major segments for expectorant drug market?

Answer: The future of the global expectorant drug market looks promising with opportunities in the hospital pharmacy, retail store, drug store, and online pharmacy markets.

Q5. Who are the key expectorant drug market companies?

Answer: Some of the key expectorant drug companies are as follows:

  • Abbott Laboratories
  • Acella Pharmaceuticals
  • AstraZeneca
  • Cipla Limited
  • Dabur
  • Glenmark Pharmaceuticals
  • Johnson and Johnson
  • Merck
  • Novartis International
  • Pfizer

Q6. Which expectorant drug market segment will be the largest in future?

Answer: Lucintel forecasts that secretion enhancer will remain larger segment over the forecast period due to they are beneficial in the management of several respiratory conditions.

Q7. In expectorant drug market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to growing number of research and development activities, along with government policies and approvals in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the expectorant drug market by drug type (secretion enhancer and mucolytics), dosage form (oral solid, oral liquid, and inhalant), product type (over-the-counter and prescription drug), distribution channel (hospital pharmacies, retail store, drug store, online pharmacies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Expectorant Drug Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Expectorant Drug Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Expectorant Drug Market by Drug Type
    • 3.3.1: Secretion Enhancer
    • 3.3.2: Mucolytics
  • 3.4: Global Expectorant Drug Market by Dosage Form
    • 3.4.1: Oral Solid
    • 3.4.2: Oral Liquid
    • 3.4.3: Inhalant
  • 3.5: Global Expectorant Drug Market by Product Type
    • 3.5.1: Over-The-Counter
    • 3.5.2: Prescription Drug
  • 3.6: Global Expectorant Drug Market by Distribution Channel
    • 3.6.1: Hospital Pharmacies
    • 3.6.2: Retail Store
    • 3.6.3: Drug Store
    • 3.6.4: Online Pharmacies
    • 3.6.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Expectorant Drug Market by Region
  • 4.2: North American Expectorant Drug Market
    • 4.2.1: North American Expectorant Drug Market by Drug Type: Secretion Enhancer and Mucolytics
    • 4.2.2: North American Expectorant Drug Market by Distribution Channel: Hospital Pharmacies, Retail Store, Drug Store, Online Pharmacies, and Others
  • 4.3: European Expectorant Drug Market
    • 4.3.1: European Expectorant Drug Market by Drug Type: Secretion Enhancer and Mucolytics
    • 4.3.2: European Expectorant Drug Market by Distribution Channel: Hospital Pharmacies, Retail Store, Drug Store, Online Pharmacies, and Others
  • 4.4: APAC Expectorant Drug Market
    • 4.4.1: APAC Expectorant Drug Market by Drug Type: Secretion Enhancer and Mucolytics
    • 4.4.2: APAC Expectorant Drug Market by Distribution Channel: Hospital Pharmacies, Retail Store, Drug Store, Online Pharmacies, and Others
  • 4.5: ROW Expectorant Drug Market
    • 4.5.1: ROW Expectorant Drug Market by Drug Type: Secretion Enhancer and Mucolytics
    • 4.5.2: ROW Expectorant Drug Market by Distribution Channel: Hospital Pharmacies, Retail Store, Drug Store, Online Pharmacies, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Expectorant Drug Market by Drug Type
    • 6.1.2: Growth Opportunities for the Global Expectorant Drug Market by Dosage Form
    • 6.1.3: Growth Opportunities for the Global Expectorant Drug Market by Product Type
    • 6.1.4: Growth Opportunities for the Global Expectorant Drug Market by Distribution Channel
    • 6.1.5: Growth Opportunities for the Global Expectorant Drug Market by Region
  • 6.2: Emerging Trends in the Global Expectorant Drug Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Expectorant Drug Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Expectorant Drug Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Abbott Laboratories
  • 7.2: Acella Pharmaceuticals
  • 7.3: AstraZeneca
  • 7.4: Cipla Limited
  • 7.5: Dabur
  • 7.6: Glenmark Pharmaceuticals
  • 7.7: Johnson and Johnson
  • 7.8: Merck
  • 7.9: Novartis International
  • 7.10: Pfizer